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The importance of cell interaction among lymphoid cells in the development 
of immune responses is well established.  In humoral responses bone marrow- 
derived  (B)  lymphocytes  are  recognized  to  be  precursors  of  the  cells  that 
release  serum  antibody  (1-4).  Thymus-derived  (T)  lymphocytes,  on  the 
other hand,  do not  develop into  antibody-forming cells  (5)  but play an im- 
portant role in primary antibody responses by cooperating with B  cells (6,  7). 
In contrast, cellular immunity is thought to be mediated by T  lymphocytes, 
apparently without  collaboration with  B  lymphocytes. However there  is in- 
creasing evidence to suggest that cooperative interaction occurs among subsets 
of T  lymphocytes (8-11).  For example, Cantor and Asofsky proposed that a 
Ti-T~  cell  interaction  takes  place  during  the  initiation  of  graft-vs.-host re- 
sponses in F1 neonates (8, 9). 
Cytotoxic in vitro allograft responses have been shown to be mediated by 
T  lymphocytes (12,  13).  As such, they provide a convenient tool for analyzing 
the cellular requirements necessary for such a  response to occur. Experiments 
therefore were designed to evaluate in vitro the concept of T-T cell interaction 
in  cellular immunity  against  transplantation  antigens.  The  results  obtained 
are compatible with the idea that two cell types interact with each other in the 
initiation of such a response. Moreover, evidence is provided that one cell type 
acts mainly as helper  cells allowing precursor cells of cytotoxic lymphocytes 
(CL)  i to be immunized effectively. 
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Materials and Methods 
Mice.--Female CBA/H/Wehi, BALB/c,  (CBA/BALB/c)F1 hybrids, and  AKR/J  mice 
aged about 60 days were used throughout. 
Alloantigen.--Mitomycin C-treated BALB/c spleen cells (H-2  d) were used as source of cell- 
bound alloantigen. Mitomycin C  (Sigma  Chemical Co., St. Louis, Mo.)  treatment was per- 
formed at a final concentration of 40/zg/ml as described (14). 
Treatment with AKR Anti-~ C3H Serum.--Anfi-~ C3H serum was raised in AKR/J mice by 
the method of Reif and Allen (15). After inactivation at 56°C for 30  rain,  its potency was 
tested by cytotoxicity against CBA thoracic duct lymphocytes (16) and its specificity by the 
fact that CBA brain absorbed the whole cytotoxicity. Anfi-O serum was used together with 
agarose-absorbed guinea pig complement under optimal conditions for killing  T  cells as de- 
scribed elsewhere (13). 
Peritoneal Exudate Cdls.--CBA mice 6-9 mo of age were injected intraperitoneally with 
1 ml of sterile proteose peptone broth (Difco Laboratories, Inc., Detroit, Mich.). 4 days later 
the peritoneal exudate cells  (PEC) were harvested into phosphate-buffered  saline. PEC were 
treated with AKR anti-O C3H serum plus complement before using them in culture. 
Cell Separation Method.--CBA  thymocytes were  separated  into  low-density and  high- 
density ceils by centrifugation on a  discontinuous albumin gradient (d 1.077 g/cm  3 to 1.088 
g/cm  3) as described by Shortman et al.  (16). The low-density cells that have been shown to be 
unreactive in in vitro allograft responses  2 were used as "filler cells." 
Cell Preparations.--Single-cel]  suspensions of thymocytes and spleen ceils were performed 
as described (13, 14). 
Peripheral Blood Lymphocytes (PBL).--PBL were prepared by collecting blood of CBA 
mice into phosphate-buffered saline containing 100 IU heparin per ml. The cells were spun 
down at 600 g for 7 min and resuspended in 0.17 ~  NH4C1. After 5 min at room temperature, 
1 ml of fetal calf serum (FCS)  was layered below the cell suspension and the cells were centri- 
fuged (600 g, 5 min). The pellet of cells was washed once with culture medium. 
Ln cells were prepared by dissecting the inguinal and axillary LN of CBA mice and teasing 
the tissues through an 80 gauge stainless steel sieve into cold culture medium. Thoracic duct 
lymphocytes (TDL) of CBA mice were obtained by cannulation of the thoracic duct basically 
according to the method described by Woodruff (18) and Sprent (19). 
Allografl Response against H-gd-Transplantation Antigens.--The culture system used was 
that of Marbrook  (20) as described by Diener and Armstrong (21). In brief 15  X  106 H-2  k 
lymphocytes (either CBA mouse or AKR mouse derived or a mixture of both) were cultured 
together with 2 X  106 mitomycin C-treated allogeneic BALB/c spleen cells. The cell suspen- 
sion was placed in a glass tube of a diameter of 1.0 cm, sealed off by a dialysis membrane, and 
suspended from the stopper of a  125 ml Elenmeyer flask  containing tissue culture medium. 
The cultures were usually terminated at day 6, which was the optimum for the generation of 
cytotoxic activity (13). Cultures were set up in triplicate. Eagle's minimal essential medium 
with supplementary nonessential amino acids was obtained from Grand Island Biological  Co., 
Grand Island, N.Y. This was supplemented with 5% FCS  (Commonwealth Serum Labora- 
tories, Melbourne, Australia), 100 #g/ml of streptomycin, 100 U/ml of penicillin G and was 
buffered with sodium bicarbonate. Cultures were placed in a humidified incubator at 37°C in 
an atmosphere of 10% CO2 in air. 
Call-Mediated Cytotoxic Assay.--The  51Cr assay used was a modification of that described 
by Brunner et al.  (22) and was performed as described previously in detail (13, 23). 
Labding  of Target Cdls.--As  BALB/c  (H-2  a)  and  DBA/2  (1t-2  d)  mice are  of identical 
H-2 specificity,  the DBA/2-derived mastocytoma line P815X-2  was used as target cells in the 
2 Wagner, H., and K. Shortman, manuscript in preparation. HERMANN  WAGNER  1381 
cytotoxicity assays.  This cell llne was kept in continuous exponential culture by Dr. Alan W. 
Harris. Usually 5 X  106 cells were labeled with 100 #Ci of chromate (51Cr) (CEA, Gif-Sur- 
Yvette, France) in a final volume of 1 ml of fortified  Eagle's medium ([FEM]  Grand Island 
Biological Co.) for 30 min at 37°C in an incubator gassed with 10% CO2 in air. The cells were 
washed twice through FCS and adjusted to a concentration of 105 cells per 100 #l. 
Assays.--At  termination of  the  culture,  cells  from  triplicate  cultures were  harvested, 
pooled, and washed twice. The viability of the cultured cells in an arbitrarily chosen reference 
group (usually LN-derived CL) was determined by the eosin dye exclusion method and the cell 
concentration adjusted to 0.66 X  106 medinm-to-large-sized  viable lymphocytes/ml. 
Usually a dilution of 1 to 6 (3), and 1 to 36 (18) was performed and triplicates of 1 ml of 
each cell dilution were assayed for cytotoxicity against 5 X  104 target cells. In actual fact 1 ml 
of the respective cell suspension was pipetted to 35 X  10 mm Petri dishes  (Falcon Plastics, 
Div. of BioQuest, Oxnard, Calif.) and 50 #l of target cells (5 X  104) were added, resulting in a 
ratio of cultured viable cells to  SlCr-labeled  target cells given. Each of the assays was per- 
formed in triplicate. Similarly to the cells of the reference  group, cells of the other cultures 
were harvested, pooled and adjusted to the same volume as the reference cells, and diluted in 
equal manner in order to compare on a culture basis the cytotoxic activity generated relative 
to that obtained in the reference  culture. The dishes were placed in an airtight box, gassed 
with 10% CO2, and rocked  on a platform for 200 min. The cells were  then harvested and 
transferred into plastic tubes; a drop of 20% sheep erythrocytes solution was added; the cells 
were centrifuged; and the supernatant was separated from the pellet. The radioactivities of 
the supernatant and pellet were determined in an automatic well-type radiation counter and 
the results expressed as per cent of maximal 51Cr release as determined by freezing and thaw- 
ing 5 X  104 labeled target cells four times (13). 
X-Irradiation.--Thymocytes were  irradiated with 800 rad in a  Philips (RT 250)  X-ray 
machine. Details of the irradiation technique for cells have been given by Miller and Sprent 
(24). 
Adult Thymectomy.--Adult thymectomies of CBA mice were performed according to the 
method of Miller (25). 
RESULTS 
Heterogeneity among  T  Lymphocytes  in their Capacity to Mount a Cell-Medi- 
ated Immune  Response  (CMI) In  Vitro.--The  generation  of  CL  in  in  vitro 
mouse allograft responses has been shown to be a  function of thymus-derived 
(T)  lymphocytes  (12,  13).  It was  of interest therefore  to  investigate whether 
there  exists a  heterogeneity within T  lymphocytes as obtained from different 
tissues in regard to their capacity to differentiate into cytotoxic effector  cells. 
First, the number of mitomycin C-treated allogeneic BALB/c spleen cells that 
elicited in 15  X  10  6 CBA mouse-derived responder  cells (H-2 k) optimal cyto- 
toxic  allograft  responses  was  determined.  It  was  found  that  2  X  10  6 mito- 
mycin C-treated  allogeneic BALB/c  spleen  cells were  optimal  (Fig.  1).  In  a 
second step, a quantitative comparison of the cytotoxic responses obtained with 
different  responder  cells  was  performed.  In  these  experiments  thymocytes, 
splenic lymphocytes, LN cells, PBL, and TDL  were tested. The respective cell 
populations (15 X  10  6) were cultured with cell-bound alloantigen (2 X  10  6 mito- 
mycin C-treated  BALB/c  spleen cells)  for  6  days and the cytotoxic response 
generated was compared on a  culture basis relative to that obtained with LN 1382 
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FIG.  1.  Dose-response relationship  between  cytotoxic  allograft  response generated  and 
number of aUogeneic stimulator  cells used. CBA mouse-derived LN cells (15  X  106) were 
cultured for 6 days together with a graded number of mitomycin C-treated  BALB/c spleen 
cells. In vitro-generated cytotoxicity was compared relative to that obtained when 2 X  106 
allogeneic stimulator  cells were used. Single stars represent background lysis of P815 target 
cells in the presence of normal LN cells. 
cells. The results of a  typical experiment are illustrated  in Fig. 2. Two points 
are  to  be  discussed.  First,  there  existed  a  linear  relationship  between  per- 
centage of lysis and the ratio CL to target cells used, if the latter was plotted 
in a  log scale.  Consequently this linear relationship allowed the determination 
of the ratio CL to target cells necessary to obtain 50 %  lysis. Since the overall 
number of responder  cells at  the  initiation  of the  culture was kept  identical, 
the precursor cell potential for CL of the different cell populations could thus 
be compared quantitatively in terms of the ratio CL to target cells that resulted 
in 50 % lysis. The reciprocal value of this ratio was defined as lysis unit. Second, 
within  thymus-processed  lymphocytes,  there  existed  a  heterogeneity  in  their 
capacity to differentiate  in vitro  into  cytotoxic effector cells.  Thus LN cells, 
PBL, and TDL  (which generated CL able to lyse 50 %  of the target cells at a 
ratio  of about  1:1)  were  found  to be four  times  more reactive  than  splenic HERMANN WAGNER  1383 
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FIO. 2. Comparison of the cytotoxic response of lymphocytes obtained from various tissues 
(A-A-A,  TDL;  O-O-C),  LN  cells; 0-0-0,  PBL;  A-A-A,  splenic lymphocytes; 
[~-n-[], thymocytes). Responder cells (15  X  106) were cultured together with 2 X  106 
allogeneic mitomycin C-treated BALB/c spleen cells. In vitro-generated cytotoxic activity 
was compared on a cu]ture basis relative to that obtained with LN cell-derived CL in a 51Cr 
assay for 200 min. ~  represents background lysis of P815 target cells. 
lymphocytes (50% lysis at a ratio of about 4:1) and 20-fold more reactive than 
thymocytes. That in  all cell populations  the responding  cells were 0-positive 
cells was strongly suggested by the fact that  treatment  of the  reactive cells 
before culture with AKR anti-0  C3H serum plus complement abolished their 
capacity to generate CL in vitro and that in vitro-generated CL were susceptible 
for lysis by such a treatment (12,  13 and Tables III and V). 
Limiting Dilution of Responder Cells.--The  effect of "limiting"  dilution  of 
responder  lymphocytes per  culture  upon  the  magnitude  of  cytotoxic  allo- 
graft response generated was investigated. In these experiments CBA mouse- 
derived LN cells (CBA LN cells) were used (containing about 80 % of periph- 
eral T  lymphocytes). Since macrophages have been shown to be essential in 
the induction  phase of T  cell-mediated in  vitro allograft responses  (23)  and 
since  PEC  could substitute  for macrophages, 0.5  X  106  CBA mouse-derived 
PEC devoid of T cells (23) were added per culture to provide a sufficient number 
of macrophages. To keep the cell density per culture of CBA-derived lympho- 
cytes constant, advantage was taken of the fact that high density (1.077 g/cm  ~) 
CBA thymocytes obtained from cell fractions of a continuous albumin gradient 
were  found  to  be  unresponsive  in  in  vitro  allograft  responses2  Thus  high- 
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density CBA thymocytes were used as a  source of inert CBA lymphocytes in 
order to keep the number of CBA lymphocytes (15  X  106) per culture con- 
stant.  The results of a  representative experiment are given in  Fig.  3.  There 
was a  sigmoidal relationship noted between the number of reactive LN cells 
and the cytotoxic response generated. For example, 1-5  X  106 CBA LN cells 
resulted in poor cytotoxic responses.  About  15  X  10  ~ reactive LN cells per 
culture were found to generate optimal cytotoxic allograft responses. Similar 
results were obtained using X-irradiated  CBA thymocytes as source of filler 
CBA lymphocytes. 
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FIG.  3. Effect of limiting dilution of responder cells upon cytotoxic response generated. A 
graded number of LN cells (from 1-15 X  l0 6) was cultured together with 2 X  10 e mitomycin 
C-treated allogeneic BALB/c spleen cells. In order to keep the cell density in all cultures con- 
stant (]5 X  10 6) varying numbers of high-density thymocytes were used as filler cells. In vitro- 
generated cytotoxicity was compared on a culture basis relative to that obtained with 15 X  10 6 
LN cells.  The results are expressed in ]ysis units. 
Synergy among Thymocytes and LN Cdls.--Since few CBA LN cells  (1-5  X 
106) in the presence of high-density or X-irradiated thymocytes yielded poor 
cytotoxic  allograft  responses  when  cultured  together  with  cell-bound  allo- 
antigen (Fig. 3), the cytotoxic response obtained in a mixture of few CBA LN 
cells (1.5  X  l0  s)  and normal CBA thymocytes (14  X  106) was investigated. 
Surprisingly it was found that such a  cell mixture yielded cytotoxic allograft 
responses  the  magnitude  of which  equaled  or  exceeded that  obtained using 
15 X  106 CBA LN cells as responder cells (Fig. 4). Since 15 X  106 thymocytes 
alone and 1.5  X  l0  s CBA LN cells  (in the presence of 14 X  106 high-density HERMANN  WAGNER  1385 
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FI6. 4. Synergy between thymocytes and LN ceils in cytotoxic allograft responses. A-A-A, 
thymocytes (15  X  106); A-~,-A, mixture of LN ceils (1.5 X  106) and high-density  thy- 
mocytes (14 X 106); @- •- •, LN cells (15 X 10 s) ; O-©-©, mixture of LN cells (1.5 X 106) 
and thymocytes (14 X  106). Each of the respective  lymphocyte populations  was cultured 
together with 2 X  10 G  mitomycin C-treated BALB/c spleen cells. In vitro-generated cyto- 
toxicity was compared on a culture  basis relative to that obtained with 15 X  10 ~ LN cells. 
The single points represent background  lysis of P815 target cells. 
or X-irradiated  thymocytes) generated poor cytotoxic activity,  the magnitude 
of cytotoxic response obtained with a mixture of both was about 20-fold greater 
than one would predict.  Similar types of synergy could be demonstrated using 
mixture of 1.5  X  106 CBA mouse-derived PBL or TDL and syngeneic thymus 
cells (Tables I  and II). 
The Cellular Requirements for the Synergistic Effect.--CBA LN cells (or PBL 
or TDL) represent a mixture of about 70-80% peripheral T  cells  and  20%  B 
lymphocytes  (26).  It  was  therefore  of  interest  to  determine  the  cell  type 
responsible within LN cells for the synergistic phenomena described.  The fact 
that treatment  of LN cells  (or TDL)  with AKR anti-0  C3H serum plus com- 
plement before culture abolished the capacity of the remaining cells to mount 
cytotoxic allograft responses and to yield synergism with thymocytes strongly 
suggested that they were T  cells in type (Table III). In addition,  mitomycin C 
treatment  of  both  thymocytes  or  LN  cells  abrogated  the  synergistic  effect 
indicating that both cell populations must be able to undergo cell proliferation. 
This  conclusion  was  supported  by  the  finding  that  (CBA  X  BALB/c)  F1 1386  T-T  CELL  INTERACTION  IN  VITRO 
TABLE  I 
Synergy between Thymoeytes and PBL in Cytotoxic Allograft Responses 
% Lysis (~lCr assay)* 
Responder cells (H-2  ~)  Ratio CL to target cells 
12:1  2:1  0.3:1 
15 X  106 PBL 
15 X  106 thymocytes 
1.5 X  106 PBL plus 14 X  106 
irradiated  thymocytes 
1.5 X  10 6 PBL plus 14 X  10 6 
high-density thymocytes 
100  75  4-  2.8  30  4-  1.2 
42  4-  1.5  20  4-  0.4  12  4-  2.0 
24  4-  2.1  13  4-  1.7  12  4-  1.9 
27  4.  0.6  15  4-  2.1  11  4-  3.6 
1.5 X  106 PBL plus 14 X  106  100  82  4-  0.6  33  4-  1.5 
thymocytes 
* Responder  cells  (H-2  k)  were  cultured  together  with  2  X  106  mitomycin  C-treated 
allogeneic BALB/c (H-2  d) spleen cells. Cytotoxic activity generated in vitro was assayed in a 
51Cr test for 200 min. Cytotoxicity obtained was compared on a  culture basis relative to the 
cytotoxicity generated  by PBL-derived  CL.  Background lysis of P815  target  cells  (in  the 
presence of normal lymphocytes) was 12 -4- 1.3%. 
TABLE  II 
Synergy between Thymocytes  and TDL in Cytotoxic Allograft Responses 
% Lysls (51Cr assay)* 
Responder cells (H-2  ~)  Ratio CL to target cells 
12:1  2:1  0.33:1 
15 X  106 TDL  98  -4-  1.9 
15  X  106 thymocytes  24  4-  0.3 
1.5 X  106 TDL plus 14 X  106  21  4-  1.4 
irradiated  thymocytes 
1.5 X  106 TDL plus 14 X  106  100 
thymocytes 
64  4-  2.4  36  4-  1.8 
13  4-  1.5  9  4-  2.1 
11  4-  1.6  10  4-  0.9 
61  4.  1.7  35  4-  1.2 
* Responder  cells  (H-2  k)  were  cultured  with  2  X  106  mitomycin  C-treated  allogeneic 
BALB/c (H-2  u) spleen cells. Cytotoxic activity generated in vitro was assayed in a  ~lCr test 
for 200 min. Cytotoxicity obtained was compared on a culture basis relative to the cytotoxieity 
generated  by  PBL-derived  CL.  Background  lysis of  P815  target  cells  (in  the presence  of 
normal lymphocytes) was 9  -4- 1.7%. HER_MANN  WAGNER 
TABLE III 
Cellular Requirements  for Synergistic Effect 
1387 
Responder  cells  (H-~) 
% Lysis (sXCr Test)* 
Ratio CL to target cells 
12:1  2:1  0.3:1 
15 X  106 CBA LN cells 
1.5 X  105 CBA LN cells plus 
14 X  106 thymocytes 
1.5 X  106 CBA LN cells treated 
with anti-0 serum and C plus 
14 X  106 thymocytes 
1.5 X  106 CBA LN cells plus 
14 )K  106 thymocytes  mitomycin 
C treated 
1.5 X  106 CBA LN cells mitomycin 
C treated  plus 14 X  106 
thymocytes 
1.5 X  106 FI(CBA X BALB/c) 
LN cells plus 14 X  106 thymo- 
cytes 
1.5 X  10  6  CBA LN cells  plus 
14 X  10  6  FI(CBA X  BALB/c) 
thymocytes 
100  79  ±  1.9  32  ±  1.6 
100  72  ±  2.3  30  ±  0.8 
29  -4-  1.2  14  -4-  2.7  11  ±  0.2 
24  -4-  2.4  13  4-  1.4  10  ±  2.1 
31  q-  1.1  15  ::t:: 1.8  11  -4-  1.6 
28  q-  1.7  14  :h  0.9  10  :t:  1.8 
21  ±  1.3  13  ±  2.8  11  -4-.1.5 
C =  complement. 
* Responder  cells were cultured  together  with 2  X  l0 s mitomycin  C-treated  allogeneic 
BALB/c (H-2  a)  spleen cells. Cytotoxic  activity generated  was assayed  in a  SlCr test for 
200 rain. Cytotoxic activity generated was compared on a culture  basis relative to the cyto- 
toxicity generated  by 15 X  106 CBA LN cells. Background lysis of P815 target cells (in the 
presence of normal lymphocytes) was 10:4- 1.0%. 
hybrid mouse-derived thymocytes or LN cells, which are genetically tolerant 
of the  alloantigen used,  could not generate  the  synergistic effect. In one out 
of five experiments, however, a mixture of (CBA X  BALB/c) FI mouse-derived 
thymocytes and CBA LN cells generated enhanced cytotoxic allograft responses. 
No synergy with either thymocytes or LN cells was observed when CBA spleen 
cells were used as reacting lymphocytes (Table IV). In contrast subpopulations 
of  CBA  spleen  cells  separated  on  a  continuous  albumin  gradient  produced 
synergy  together with peripheral  T  cells.*  The  results  given in  Table  IV  il- 
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TABLE IV 
Failure of Synergy between Thymocytes and Spleen Cells 
Responder  cells (H-2  k) 
% Lysis (~lCr test)* 
Ratio CL to target cells 
12:1  2:1  0.3:1 
15 X  106 LN cells  100  82  4.  1.4  40  4-  2.3 
15 X  100 AT-LN ceils  100  56  4-  4.1  29  4.  0.6 
15  X  106 thymocytes  26  4-  1.4  11  4-  1.6  9  -4-  2.3 
1.5 X  10 G  LN cells plus 14 X  106  100  53  4-  2.3  31  4-  1.9 
thymocytes 
1.5 X  106 AT-LN ceils plus  100  86  4-  1.8  39  4-  2.6 
14 X  106 thymocytes 
15 X  106 spleen cells  82  4-  1.1  43  4-  1.5  14  4-  0.3 
1.5 X  106 AT-LN cells plus  80  4-  2.8  45  4-  1.0  16  4-  1.7 
14 X  106 spleen cells 
1.5 X  106 LN ceils plus 14 X  106  84  4-  0.8  40  4-  2.3  18  4-  1.6 
spleen cells 
1.5 X  106 spleen cells plus 14X  106  39  4-  1.6  14  4-  3.3  10  4-  0.8 
thymocytes 
* AT-LN =  LN cells of adult thymectomized mice 6 wk after  operation. Responder cells 
were cultured  together with 2 X  106 mitomycin C-treated  a]logeneic BALB/c (H-2  d) spleen 
cells. Cytotoxic activity generated was assayed in a  51Cr test for 200 min. Cytotoxicity  was 
compared on a culture basis relative to the cytotoxicity generated by 15 )< 106 CBA LN cells. 
Background lysis of P815 target cells was 10 4. 2.3%. 
lustrate  also that  LN ceils of adult  thymectomized CBA mice were found  to 
produce a  high degree of synergy together with CBA thymocytes. 
Limiting Dilution of LN Cells in the Presence  of Normal  Thymoeytes.--The 
effect of a  limiting dilution of LN cells in regard to the synergy of thymocytes 
and LN cells during cytotoxic allograft responses  was  investigated. A  graded 
number of CBA LN cells  (from 2  X  106  to 0.1  X  106) was mixed with  14  X 
106  CBA thymocytes and  the  cell mixture  cultured  together with  cell-bound 
alloantigen. The results given in Fig. 5  demonstrate that as few as 0.1  X  106 
LN cells,  a  number far  too small to produce any response alone  (Fig.  2),  re- 
sulted in  significant enhancement  of  the  cytotoxic response  generated.  When 
for each group the ratio CL to target cells was determined that resulted in 50% 
lysis and the lysis units were plotted against the respective number of LN cells tIERMANN  WAGNER  1389 
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FIo. 5. Effect of limiting dilution  of LN cells upon  the synergistic interaction  between 
thymocytes and LN cells. D-D-D, thymocytes  (15 X  106); -~-~-~, mixture of LN cells 
(2 X  106) plus 14 X  106 irradiated  thymocytes. The cell concentration indicates the number 
of LN cells cultured together with 14 X  106 thymocytes. Each of the respective lymphocyte 
populations was cultured  together with 2 X  106 mitomycin C-treated  BALB/c spleen ceils. 
In vitro-generated cytotoxicity was compared on a culture basis relative to that obtained with 
a mixture of LN ceils (2 X  106) and thymocytes  (14 X  106). ~- represents background lysis 
of P815 target cells. 
used, a linear relationship between cytotoxic activity generated and the number 
of reactive LN cells was noted  (Fig. 6). This finding suggested that the mag- 
nitude  of the  enhanced  cytotoxic activity generated  in  a  mixture  of thymo- 
cytes and LN cells correlated to the number of reactive LN cells present. 
Effect of Graded Numbers of Thymocytes  in the Presence of a Constant Number 
of  LN  Cells.--Since  the  magnitude  of  cytotoxic  responses  generated  by  a 
mixture of 14 X  106 thymocytes and limited numbers of LN cells appeared to 
correlate to the number of LN cells present  (Fig. 6), it was of interest  to per- 
form the reciprocal experiment.  Assuming that the majority of precursor cells 
of CL was LN cell derived and the thymocytes provided a  source of "helper 
cells,"  one would predict  that a  critical  number of thymocytes was sufficient 
to allow all potential reactive LN cells to be activated. Further increase of the 
number of thymocytes beyond optimal concentration should not alter markedly 
the final magnitude of the cytotoxic response obtained.  The experiment to be 
performed  involved  three  cell  populations:  a  constant  number  of  CBA LN 
cells  (1.5  X  106),  a  graded number  of CBA thymocytes, and  2  X  106 mito- 
mycin  C-treated  allogeneic  BALB/c  spleen  cells.  The  results  of  a  typical 
experiment  are  illustrated  in  Fig.  7.  It is  immediately  apparent  that  in  the 1390  T-T CELL INTERACTION  IN  VITRO 
presence of less than 2  X  106 CBA thymocytes a  poor cytotoxic response was 
obtained. There was a  sharp rise of the  cytotoxic response when 2-4  X  106 
thymocytes were cultured together with 1.5  X  106 LN cells. More  than  6  X 
106 thymocytes yielded only a limited further increase of the cytotoxic response. 
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FIO. 7. Effect of limiting dilution of thymocytes in the presence of a constant number of 
LN ceils (1 X  106) upon the magnitude of cytotoxic response generated. A-/k-A, response 
of a mixture of a graded number of thymocytes in the presence of a constant number (1 X 106) 
of LN cells; O-O-C), response of thymocytes Mone. Each of the respective lymphocyte popu- 
lations was cultured together with 2 X 106 mitomycin C-treated BALB/c spleen cells. In vitro- 
generated cytotoxicity was compared on a culture basis relative to that obtained with a mix- 
ture of LN cells (1 X 106) and thymocytes (14 X 106). The results are expressed in lysis units. HERM_ANN WAGNER  1391 
Evaluation  of the Respective Contribution  of Thymocytes  and LN Cells to the 
Final Cytotoxic Activity Generated.--AKR mice and  CBA mice are of identical 
H-2  specificity  (27) but differ in the ~b-antigen phenotype  (26). The possibility 
was therefore tested of producing synergy in a  mixture of AKR  thymocytes and 
CBA  LN  cells  (or vice versa)  and  of using AKR  anti-¢  C3H  serum in order 
to kill out the CBA mouse-derived q~-positive CL before the 51Cr  cytotoxicity 
assay.  It was  argued that  the remaining CL might then be identified as being 
AKR  thymocyte  derived  (or  vice versa).  The  experiments  given in Table  V 
TABLE  V 
Synergy between AKR (H-2  k) and CBA  (H-g  k) Lymphocytes in Cytotoxic Allograft Responses 
Responder calls (//-g~) 
% of Lysis (61Cr test)* 
Ratio CL to target cells 
12:1  2:1  0.3:1 
1.5 X  106 AKR-LN cells plus  100 
14 )<  106 CBA thymocytes 
15 X  106 CBA thymocytes 
15 X  106 AKR thymocytes 
1.5 X  106 AKR-LN cells plus 
14 X  10 G  irradiated CBA 
thymocytes 
* 1.5 X  106 AKR-LN cells plus  100 
14 X  100 AKR thymocytes 
Cytotoxic activity after AKR  100 
anti-0 C3H serum treatment plus 
C 
1.5 X  106 CBA LN cells plus 
14 X  106 CBA thymocytes 
Cytotoxic activity after AKR anti-8 
C3H serum treatment plus com- 
plement 
83  4-  2.3  41  4-  0.4 
38  4-  2.1  23  4-  1.4  10  4-  0.8 
19  4-  1.9  10  4-  2.2  9  4-  2.1 
21  4-  2.0  11  4-  1.5  N.D. 
72  4.  2.4  34  4-  1.2 
69  4-  1.6  33  4-  0.7 
99  4-  2.9  56  4-  1.6  23  4-  2.5 
10  -4-  2.1  9  4-  1.4  9  4-  3.1 
N.D.  =  not done. 
* Responder  cells  (H-2  k)  were  cultured  together  with  2  X  l0 s  mitomycin  C-treated 
allogeneic BALB/c spleen cells.  In the case of groups * and ~, nine cultures were set up in- 
stead of three. Mter 6 days culture cells per group were harvested. Each cell pool of group 
* and :~ was divided into three equal parts. One part remained untreated, one part was treated 
with normal AKR serum plus complement, and one part was treated with AKR anti-0 C3H 
serum plus complement. Cytotoxic activity of each cell pool was then assayed in a  51Cr test 
for 200 min and compared relative to the cytotoxic activity obtained with a mixture of AKR- 
LN plus CBA thymocytes. Background lysis of P815 target cells was 9 -4- 1.7%. 1392  T-T  CELL  INTERACTION  IN  VITRO 
demonstrate  that  synergy  occurred  within  a  mixture  of  AKR  thymocytes 
and  CBA LN cells or CBA thymocytes and AKR LN  cells, provided the cell 
mixtures  were  cultured  together  with  alloantigen.  In  addition,  evidence was 
obtained that AKR mouse-derived CL,  unlike CBA mouse-derived CL,  were 
not killed by treatment with AKR anti-~b C3H serum. Therefore, AKR anti-q~ 
CBA  serum  could be used in  order  to  discriminate between  CBA ~b-positive 
cells within a  CL cell population. Fig. 8 a  illustrates the results of a  quantita- 
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17m. 8.  Discrimination between  thymus  or T  cell-derived  CL.  (a)  A-A-/k, cytotoxic 
allograft response obtained by a mixture of AKR mouse thymocytes (14 X 10 6) and 1.5 X 10 6 
CBA mouse-derived LN cells; O-O-C), residual  activity after treatment with AKR anti-8 
C3tt serum plus complement.  D-O-D, response of 15 X  10 6 AKR thymecytes. -~-~-$, 
response of 1.5 )< 10 6 CBA LN cells in the presence of 14 X  10 6 high-density thymocytes. (b) 
/k-A-/k, cytotoxic ailograft response obtained  by a  mixture  of  CBA mouse  thymocytes 
(14 X  10 6) and 1.5 X  10 6 AKR mouse LN cells. O-O-C), residual activity after treatment 
with AKR anti-O C3H serum plus complement;  -~--~-~-, response of 1.5 X  106 AKR LN 
cells in the presence of high-density thymocytes; D-Q-D, response of 15  X  106 CBA thy- 
mocytes. 
tion of the contribution of 14 X  106 AKR mouse-derived thymocytes within a 
mixture of AKR  thymocytes and  1.5  X  106  CBA LN cells to the final cyto- 
toxic activity. It is apparent that  about 70 %  of the overall cytotoxicity was 
specifically lost after treatment with AKR anti-(# C3H  serum.  The results of 
the reciprocal experiment given in Fig. 8 b suggest that 1.5  X  106 AKR mouse- 
derived  LN  cells when  cocultivated with  14  X  106  CBA  thymocytes  con- 
tributed about 70% to the final cytotoxic activity. These experiments suggsted 
that within a  mixture of thymocytes and LN  cells the majority of precursor HERMANN  WAGNER  1393 
cells of CL was LN derived. However, also the cytotoxic response of the thy- 
mocytes was  increased in  the presence of reacting LN  cells.  Thus,  whereas 
thymocytes when cultured alone with alloantigen yielded CL able to lyse 30  ° 
35 % of the target cells at a ratio of 12:1 (Fig. 8 b), in the presence of respond- 
ing LN cells up to 70 % of the target cells were lysed by CBA mouse thymus- 
derived CL. 
DISCUSSION 
This paper describes a  synergistic cell interaction between murine  thymo- 
cytes  and  peripheral  T  lymphocytes during  in  vitro  cytotoxic allograft  re- 
sponses.  Synergy was  demonstrated by combining T  cells  from tissues com- 
paratively active in mounting in vitro cytotoxic allograft responses such  as 
lymph node cells,  PBL,  or TDL with cells from a  tissue with  less  activity, 
such  as  the  thymus.  Evidence was  obtained that  the bulk  of the  cytotoxic 
activity generated was mediated by CL derived from peripheral T  cells.  Yet 
peripheral T  cells  required  the  presence of immune  reactive thymocytes in 
order to be optimally immunized in vitro. 
Cytotoxic in vitro allograft responses are mediated by T  lymphocytes (13) 
and thus provide a  convenient tool for analyzing the concept of T-T cell in- 
teractions (11) during cell-mediated immune responses. It was noted that T-cell 
populations as obtained from lymph nodes or the thoracic duct of nonimmu- 
nized mice were able to mount a  good cytotoxic allograft response in vitro. 
Therefore it was concluded that if T-T cell interactions occurred during in vitro 
cytotoxic allograft responses, then both T-cell subsets must be present in the 
responder T-cell population.  Consequently, we first screened different T-cell 
sources and  assessed  their relative capacities to mount a  cytotoxic allograft 
response on their own. It was found that lymphocytes obtained from tissues 
containing about 80%  (25)  of recirculating T  cells such as LN cells,  PBL, or 
TDL generated up to 20-30-fold more cytotoxic activity than did thymocytes. 
Spleen cells were found to be three to four times more active (Fig. 2). In order 
to test for the concept of T-T cell interaction in the in vitro allograft response, 
1.5  X  106 LN cells,  numbers too small  to yield good cytotoxic effector cells 
(Fig. 3),  were mixed with syngeneic thymocytes (14  X  106) and cultured in 
vitro  together with  allogeneic lymphoid cells.  Such  cell mixtures proved to 
yield cytotoxic responses that exceeded by far the expected sum of the control 
cultures and that were comparable in magnitude to those obtained with 15 X 
l0  G  LN cells (Fig. 3, Tables I and II). 
The fact that  the reactive cells within LN cells  were Q-positive suggested 
strongly that they were T  lymphocytes (Table III). As synergy between thy- 
mocytes and T  cells was inhibited by treatment of either cell population with 
mitomycin C, an agent which inhibits cell proliferation, it appeared that for 
synergy to occur, both thymocytes and T  cells had to be able to undergo cell 
proliferation. Further support for this notion was obtained by the finding that 1394  T-T  CELL  INTERACTION  IN  VITRO 
lymphocytes derived from (CBA X BALB/c) F1 hybrid mice, which for genetic 
reasons  are  unresponsive  against  BALB/c  alloantigens,  were  ineffective in 
producing synergy (Table III). No explanation can be offered at present,  as 
to why in one experiment out of five, thymocytes derived from F1 hybrid mice 
produced synergy with CBA LN cells in the response to H-2  ~ alloanfigen. It 
was also found that  spleen cells, either  mixed with LN cells or with thymo- 
cytes,  failed to  produce  synergy (Table  IV),  although  spleen  cells  of  mice 
treated in vivo with moderate doses of antithymocyte serum produced synergy 
with peripheral T  cells. 5 Moreover, when spleen cells were separated on a con- 
tinuous albumin gradient,  distinct cell  fractions were  obtained that  yielded 
synergy with peripheral T cells3 Finally, as TDL obtained from adult thymec- 
tomized mice 6 wk after operation were efficient in producing synergy together 
with thymocytes, it appeared that long-lived, recirculating T lymphocytes were 
interacting with thymocytes in the in vitro system used (H. W., unpublished 
observations). 
Linliting dilution experiments performed with both thymocytes and recir- 
culating T  cells  suggested that the magnitude of the cytotoxic response ob- 
tained correlated to the number of peripheral T cells present rather than to the 
number of thymocytes (Fig. 6 and 7). This notion was supported by the fact 
that the bulk (about 70 %) of the cytotoxic activity generated within a mixture 
of thymocytes (14 X  10  ~) and LN cells (1 X  l0 s) was LN cell derived (Fig. 8). 
Therefore it appeared that thymocytes were mainly acting as helper cells. The 
results reported are similar to those of Cantor and Asofsky (8, 9)  as obtained 
in a graft-vs.-host system, with the exception that under the in vitro conditions 
used here the major source of precursor cells of effector cells  appeared to be 
provided by peripheral T  cells. 
At present the mechanism of the T-T  cell  synergism during in vitro allo- 
graft responses is not understood. Any interpretation should take into account 
(a)  that the allograft system used is modeled on a  "one-way" mixed lympho- 
cyte culture  (MLC)  using allogeneic lymphoid cells  as  stimulator cells  and 
consider (b) the recent demonstration of a third locus (MLC locus) in the genetic 
region  of  the  major  histocompatibility  complex  (MHC)  (28-30).  Unlike 
the two loci  (H-2K and H-2D in the mouse), which control serologically de- 
fined (H-2)  antigens, the third locus (MLC locus)  appears  to be responsible 
for allogeneic differences that result in cell proliferation in the MLC, yet are 
not detectable serologically (lymphocyte-defined [LD]  antigens). In addition, 
all  evidence available  suggests  that  the  cytotoxic action of  CL  is  directed 
against serologically defined (SD)  (H-2)  antigens of the target cells  (29, 31). 
Thus  the  paradoxical  situation  has  to  be  considered  that  two  "antigens" 
(SD and LD) appear to be responsible for the MLC reaction, however, that the 
cytotoxic effector phase is directed only against SD  antigens. Therefore it is 
proposed  that  during  the  in  vitro  response  against allogeneic lymphocytes, 
Wagner, H., and K. Shortman,  manuscript in preparation. HER.MANN WAGNER  1395 
functional  distinct  T-cell populations  are stimulated  by different  "antigens." 
T1 cells (thymocytes or short-lived T  cells)  respond mainly against allogeneic 
LD differences; T~ cells (long-lived, recirculating T cells) react immunologically 
specific against  allogeneic SD  (H-2) antigens  and differentiate  into  cytotoxic 
effector cells. The proliferative response of T1 cells to allogeneic LD differences 
results  in  an  amplification  of a  cocomitant  T2  anti-SD  (H-2)  reaction.  The 
mechanism of amplification may be mediated by a soluble mediator produced 
by T1 cells. 
The above hypothesis predicts that allogeneic cells, such as fibroblasts, which 
do not display LD antigens, will not provoke the T1 cell-derived helper mecha- 
nisms for the stimulation  of SD antigen-reactive  T~ cells. This might  be the 
explanation  why allogeneic fibroblasts  do  not  cause as  great  cytotoxic allo- 
graft responses as do allogeneic lymphoid cells  (32).  Since mouse strains  are 
now available differing only either in SD or LD antigens  (30, 33), the validity 
of the proposed concept can soon be tested. 
SUMMARY 
A mouse in vitro allograft system was used to evaluate the concept of T-T 
interaction  in T  cell-mediated cellular immunity.  In analyzing  the responsive- 
ness  of  thymus-processed  lymphocytes  as  obtained  from  different  tissues,  a 
heretogeneity within T  cells was found in regard  to their  capacity to be im- 
munized in vitro against  transplantation  antigens.  Recirculafing T  cells were 
10-20-fold superior  to thymocytes, splenic T  cells being intermediate.  When 
few (1.5 X  l0 s) peripheral T  cells, in numbers too small to yield good cytotoxic 
responses, were mixed with 14 X  106 thymocytes and the cell mixture immu- 
nized in vitro against cell-bound alloantigens,  cytotoxic activity was generated 
exceeding about 10-20-fold the values that could be explained by a pure addi- 
tive  effect.  Synergy occurred  also in  a  mixture  of responder  T  cells derived 
from CBA (H-2 k) and AKR (H-2 k) mice. Thus AKR anfi-q~ C3H serum could 
be  used  for  discriminating  between  thymus-derived  and  peripheral  T  cell- 
derived cytotoxic lymphocytes (CL).  Cytotoxic activity produced during  the 
synergistic interaction  between thymocytes and peripheral  T  cells was about 
70 % T cell derived, the remainder being thymus derived. The synoptic interpre- 
tation  of  this  finding  and  "limiting  dilution"  experiments  of  the  responder 
cells suggested strongly that  peripheral  T  cells provide the major  source for 
precursor cells of CL, thymocytes acting mainly as helper (amplifier)  cells. 
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